A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
Nathaniel Rothman(Division of Cancer Epidemiology and Genetics), Montserrat García‐Closas(Division of Cancer Epidemiology and Genetics), Nilanjan Chatterjee(Division of Cancer Epidemiology and Genetics), Núria Malats(Spanish National Cancer Research Centre), Xifeng Wu(The University of Texas MD Anderson Cancer Center), Jonine D. Figueroa(National Cancer Institute), Francisco X. Real(Spanish National Cancer Research Centre), David Van Den Berg(University of Southern California), Giuseppe Matullo(University of Turin), Dalsu Baris(Division of Cancer Epidemiology and Genetics), Michael J. Thun(American Cancer Society), Lambertus A. Kiemeney(Radboud University Nijmegen), Paolo Vineis(Imperial College London), Immaculata De Vivo(Brigham and Women's Hospital), Demetrius Albanes(Division of Cancer Epidemiology and Genetics), Mark P. Purdue(National Cancer Institute), Þórunn Rafnar(deCODE Genetics (Iceland)), Michelle A.T. Hildebrandt(The University of Texas MD Anderson Cancer Center), Anne E. Kiltie(University of Oxford), Olivier Cussenot(Assistance Publique – Hôpitaux de Paris), Klaus Golka(TU Dortmund University), Rajiv Kumar(German Cancer Research Center), Jack A. Taylor(National Institute of Environmental Health Sciences), José Mayordomo(Universidad de Zaragoza), Kevin B. Jacobs(Science Applications International Corporation (United States)), Manolis Kogevinas(Center for Research in Environmental Epidemiology), Amy Hutchinson(National Cancer Institute), Zhaoming Wang(National Cancer Institute), Yi‐Ping Fu(National Cancer Institute), Ludmila Prokunina‐Olsson(Division of Cancer Epidemiology and Genetics), Laurie Burdett(Science Applications International Corporation (United States)), Meredith Yeager(National Cancer Institute), William Wheeler(Information Management Services), Adonina Tardón(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Cònsol Serra(Pompeu Fabra University), Alfredo Carrato(Instituto Cajal), Reina García-Closas(Hospital Universitario de Canarias), Josep Lloreta(Pompeu Fabra University), Alison Johnson(Vermont Cancer Support Network), Molly Schwenn, Margaret R. Karagas(Dartmouth College), Alan R. Schned(Dartmouth College), Gerald L. Andriole(Washington University in St. Louis), Robert L. Grubb(Washington University in St. Louis), Amanda Black(National Cancer Institute), Eric J. Jacobs(American Cancer Society), W. Ryan Diver(American Cancer Society), Susan M. Gapstur(American Cancer Society), Stephanie J. Weinstein(National Cancer Institute), Jarmo Virtamo(Finnish Institute for Health and Welfare), Victoria K. Cortessis(University of Southern California), Manuela Gago-Domínguez(University of Southern California), Malcolm C. Pike(Memorial Sloan Kettering Cancer Center), Mariana C. Stern(University of Southern California), Jian‐Min Yuan(University of Minnesota Medical Center), David J. Hunter(Harvard University), Monica McGrath(Harvard University), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), Bogdan Czerniak(The University of Texas MD Anderson Cancer Center), Meng Chen(The University of Texas MD Anderson Cancer Center), Hushan Yang(The University of Texas MD Anderson Cancer Center), Sita H. Vermeulen(Radboud University Nijmegen), Katja K.H. Aben(Radboud University Medical Center), J.A. Witjes(Radboud University Medical Center), Remco R. Makkinje(Radboud University Nijmegen), Patrick Sulem(deCODE Genetics (Iceland)), Søren Besenbacher(deCODE Genetics (Iceland)), Kāri Stefánsson(University of Iceland), Elio Ríboli(Imperial College London), Paul Brennan(Centre International de Recherche sur le Cancer), Salvatore Panico(Federico II University Hospital), Carmen Navarro(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Naomi E. Allen(University of Oxford), H. Bas Bueno-de-Mesquita(National Institute for Public Health and the Environment), Dimitrios Trichopoulos(Academy of Athens), Neil E. Caporaso(Division of Cancer Epidemiology and Genetics), Maria Teresa Landi(National Cancer Institute), Federico Canzian(German Cancer Research Center), Börje Ljungberg(Umeå University), Anne Tjønneland(Danish Cancer Society), Françoise Clavel‐Chapelon(Centre de recherche en Epidémiologie et Santé des Populations), D. Timothy Bishop(University of Leeds), Mark Teo(St James's University Hospital), Margaret A. Knowles(University of Leeds), Simonetta Guarrera(Italian institute for Genomic Medicine), Silvia Polidoro(Italian institute for Genomic Medicine), Fulvio Ricceri(University of Turin), Carlotta Sacerdote(University of Turin), Alessandra Allione(Italian institute for Genomic Medicine), Géraldine Cancel‐Tassin(Pathophysiology, Diagnosis and Treatment of Bone Diseases), Silvia Selinski(TU Dortmund University), Jan G. Hengstler(Leibniz Research Centre for Working Environment and Human Factors), H. Dietrich(Paul Gerhardt Diakonie), Tony Fletcher(London School of Hygiene & Tropical Medicine), Péter Rudnai(Orszagos Kornyezetegeszsegugyi Intezet), Eugen Gurzău(Babeș-Bolyai University), Kvetoslava Koppová, Sophia C.E. Bolick(National Institute of Environmental Health Sciences), Ashley C. Godfrey(National Institute of Environmental Health Sciences), Zongli Xu(National Institute of Environmental Health Sciences), José I Sanz-Velez(Hospital General San Jorge), María Dolores García-Prats(Hospital General San Jorge), Manuel Sanchez(Universidad de Zaragoza), Gabriel Valdivia(Universidad de Zaragoza), Stefano Porru(University of Brescia), Simone Benhamou(Institut Gustave Roussy), Robert N. Hoover(Division of Cancer Epidemiology and Genetics), Joseph F. Fraumeni(Division of Cancer Epidemiology and Genetics), Debra T. Silverman(Division of Cancer Epidemiology and Genetics), Stephen J. Chanock(Division of Cancer Epidemiology and Genetics)
Cited by 487Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis